Ann: Commencement of BNC210 Phase 2 Agitation Trial, page-34

Thank you Roka - that was a very comprehensive and informative post.

I did not realise the subtle complexities of the trial - nor the shades of colour that may be revealed by the results.

It does make sense that the company not give info on secondary endpoints if they were inconclusive.

I was also interested in the explanation of the trials "power" and the company's justification for limiting enrollments to 193 patients - it all makes perfect economic sense.

The fact that there are four symptom clusters also means that analysis and release of results may not be as quick as I had formerly hoped.

Thanks again for that info - appreciated.

on a side issue - weird market in BNO yesterday - one minute knockingon teh door of 60c again then slammed back to 55c........

Does not seem like bots but rather an active strategy to stop a break back above 60c resistance level........

Cheers.

Cheers.